Clinical Trial Update: Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicates ongoing recruitment for intranasal insulin plus glutathione as an add-on therapy in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Glutathione (glutathione)
• Intranasal insulin (insulin)

Snippet

Sponsor: Gateway Institute for Brain Research | Conditions: Parkinson Disease | Phase 2 | Status: RECRUITING